---
schema_version: "secwatch.filing_event.v1"
accession: "0001121702-24-000045"
form_type: "8-K"
ticker: null
cik: "0001121702"
company_name: "YIELD10 BIOSCIENCE, INC."
filed_at: "2024-05-15T23:59:59+00:00"
generated_at: "2026-06-01T22:37:07.017401+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Yield10 Q1 2024 net loss $2.5M, improves cash burn; milestone payments received

## Summary
- Cash at $1.6M (up from $1.1M Dec 2023); operating cash burn $0.9M vs $2.7M YoY.
- Recognized $0.3M license revenue from VISION; received $2M initial payment, additional $1M milestone in May 2024.
- Net loss $2.5M ($4.77 diluted share) compared to $3.8M ($18.16) in Q1 2023; results reflect 1-for-24 reverse split.
- EPA approved INTERLINE herbicide for Camelina; USDA-APHIS cleared commercial planting of HT Camelina.
- Building omega-3 Camelina seed inventory for aquafeed; patent granted for carbon fixation pathway and notice of allowance for yield trait C3004.

## SEC filing metadata
- accession: 0001121702-24-000045
- form_type: 8-K
- cik: 0001121702
- company_name: YIELD10 BIOSCIENCE, INC.
- filed_at: 2024-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000045/0001121702-24-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000045/yten-20240515.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001121702-24-000045
- JSON: https://secwatch.observer/filing/0001121702-24-000045.json
- Plain text: https://secwatch.observer/filing/0001121702-24-000045.txt

## Key facts
- Earnings Releases
  YIELD10 BIOSCIENCE, INC. reported financial results for the three months ended March 31, 2024.
  - Period: the three months ended March 31, 2024
  - Result: reported results
  source text: On May 15, 2024, Yield10 Bioscience, Inc. issued a press release announcing the financial results for the three months ended March 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000045/0001121702-24-000045-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.